Our data demonstrate that similar to their effect in cancer cells, TTFields application in cerebEND cells promoted a time-dependent increase in GEF-H1 S885 phosphorylation with peak levels appearing at 10 min and remaining stable through the examined treatment duration (Figure 2A,B). The gene discussed is ARHGEF2; the disease is cancer.